€121.70
0.41% yesterday
Frankfurt, Jan 30, 02:37 pm CET
ISIN
NL0012044747
Symbol
RDC
Index

Redcare Pharmacy Stock price

€121.70
-11.00 8.29% 1M
-24.30 16.64% 6M
-11.00 8.29% YTD
-9.20 7.03% 1Y
+7.30 6.38% 3Y
+75.10 161.16% 5Y
+93.20 327.02% 10Y
Frankfurt, Closing price Thu, Jan 30 2025
+0.50 0.41%
ISIN
NL0012044747
Symbol
RDC
Index
Sector

Key metrics

Market capitalization €2.43b
Enterprise Value €2.49b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 121.52
EV/Sales (TTM) EV/Sales 1.12
P/S ratio (TTM) P/S ratio 1.09
P/B ratio (TTM) P/B ratio 4.80
Revenue growth (TTM) Revenue growth 39.58%
Revenue (TTM) Revenue €2.23b
EBIT (operating result TTM) EBIT €-39.46m
Free Cash Flow (TTM) Free Cash Flow €20.49m
Cash position €209.90m
EPS (TTM) EPS €-1.23
P/E forward negative
P/S forward 1.02
EV/Sales forward 1.05
Show more

Is Redcare Pharmacy a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,875 stocks worldwide.

Redcare Pharmacy Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Redcare Pharmacy forecast:

9x Buy
75%
2x Hold
17%
1x Sell
8%

Analyst Opinions

12 Analysts have issued a Redcare Pharmacy forecast:

Buy
75%
Hold
17%
Sell
8%

Financial data from Redcare Pharmacy

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
2,227 2,227
40% 40%
100%
- Direct Costs 1,779 1,779
44% 44%
80%
448 448
24% 24%
20%
- Selling and Administrative Expenses 418 418
57% 57%
19%
- Research and Development Expense - -
-
-
30 30
69% 69%
1%
- Depreciation and Amortization 69 69
39% 39%
3%
EBIT (Operating Income) EBIT -39 -39
189% 189%
-2%
Net Profit -25 -25
51% 51%
-1%

In millions EUR.

Don't miss a Thing! We will send you all news about Redcare Pharmacy directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Redcare Pharmacy Stock News

AD HOC NEWS
17 days ago
Die Aktien von Redcare Pharmacy NL0012044747 können sich am Dienstag etwas vom Kurseinbruch vom Vortag erholen.
EQS
22 days ago
Sevenum, Niederlande, 9. Januar 2025. Redcare Pharmacy N.V. hat heute vorläufige Umsatzzahlen für das vierte Quartal und das Gesamtjahr 2024 veröffentlicht. In dem Jahr, in dem sich das elektronische Rezept in Deutschland als neuer Standard etabliert hat, verzeichnete der Konzern ein Umsatzplus b...
AD HOC NEWS
22 days ago
Die Schweizer Großbank UBS hat Redcare Pharmacy NL0012044747 nach vorläufigen Jahresumsatzzahlen auf "Sell" mit einem Kursziel von 85 Euro belassen.
More Redcare Pharmacy News

Company Profile

Shop Apotheke Europe NV engages in the provision of medication and pharmacy-related beauty and care products. It operates through the DACH and International geographical segments. The DACH segment sells prescription medicine, prescription-free pharmaceuticals, and beauty and personal care products, and functional food products to individual customers located in the German, the Austrian, and the Swiss market. The International segment trades pharmaceutical products outside European market. The company was founded by Stephan Weber and Marc Fischer in 2001 and is headquartered in Venlo, the Netherlands.

Head office Netherlands
CEO Olaf Heinrich
Employees 2,075
Founded 2001
Website www.redcare-pharmacy.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today